Macquarie Group’s Select Medical SEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-33,800
| Closed | -$564K | – | 1761 |
|
|
2025
Q1 | $564K | Hold |
33,800
| – | – | ﹤0.01% | 1459 |
|
|
2024
Q4 | $637K | Sell |
33,800
-28,933
| -46% | -$558K | ﹤0.01% | 1422 |
|
|
2024
Q3 | $1.18M | Hold |
62,733
| – | – | ﹤0.01% | 1348 |
|
|
2024
Q2 | $1.19M | Hold |
62,733
| – | – | ﹤0.01% | 1345 |
|
|
2024
Q1 | $1.02M | Sell |
62,733
-15,219
| -20% | -$223K | ﹤0.01% | 1371 |
|
|
2023
Q4 | $987K | Sell |
77,952
-96,837
| -55% | -$1.22M | ﹤0.01% | 1390 |
|
|
2023
Q3 | $2.38M | Hold |
174,789
| – | – | ﹤0.01% | 1112 |
|
|
2023
Q2 | $3M | Hold |
174,789
| – | – | ﹤0.01% | 1059 |
|
|
2023
Q1 | $2.43M | Hold |
174,789
| – | – | ﹤0.01% | 1110 |
|
|
2022
Q4 | $2.34M | Sell |
174,789
-3,168,171
| -95% | -$41M | ﹤0.01% | 1167 |
|
|
2022
Q3 | $39.9M | Sell |
3,342,960
-786,152
| -19% | -$11.2M | 0.05% | 496 |
|
|
2022
Q2 | $52.5M | Buy |
4,129,112
+27,712
| +0.7% | +$356K | 0.06% | 437 |
|
|
2022
Q1 | $53K | Buy |
4,101,400
+614,102
| +18% | +$8.11M | 0.04% | 509 |
|
|
2021
Q4 | $55.2M | Sell |
3,487,298
-42,430
| -1% | -$724K | 0.05% | 489 |
|
|
2021
Q3 | $68.8M | Sell |
3,529,728
-38,373
| -1% | -$762K | 0.06% | 428 |
|
|
2021
Q2 | $81.2M | Buy |
3,568,101
+3,420,276
| +2,314% | +$71M | 0.07% | 367 |
|
|
2021
Q1 | $2.72M | Sell |
147,825
-18,270
| -11% | -$300K | ﹤0.01% | 1084 |
|
|
2020
Q4 | $2.48M | Hold |
166,095
| – | – | ﹤0.01% | 1042 |
|
|
2020
Q3 | $1.86M | Hold |
166,095
| – | – | ﹤0.01% | 1064 |
|
|
2020
Q2 | $1.32M | Buy |
166,095
+4,499
| +3% | +$37.3K | ﹤0.01% | 1130 |
|
|
2020
Q1 | $1.31M | Buy |
161,596
+7,177
| +5% | +$85.3K | ﹤0.01% | 1024 |
|
|
2019
Q4 | $1.94M | Hold |
154,419
| – | – | ﹤0.01% | 1041 |
|
|
2019
Q3 | $1.38M | Hold |
154,419
| – | – | ﹤0.01% | 1126 |
|
|
2019
Q2 | $1.32M | Buy |
+154,419
| New | +$1.22M | ﹤0.01% | 1137 |
|
|
2018
Q3 | – | Sell |
-5,939
| Closed | -$58K | – | 2257 |
|
|
2018
Q2 | $58K | Sell |
5,939
-25,984
| -81% | -$255K | ﹤0.01% | 1929 |
|
|
2018
Q1 | $297K | Buy |
31,923
+17,075
| +115% | +$163K | ﹤0.01% | 1570 |
|
|
2017
Q4 | $141K | Sell |
14,848
-10,765
| -42% | -$103K | ﹤0.01% | 1821 |
|
|
2017
Q3 | $265K | Buy |
+25,613
| New | +$236K | ﹤0.01% | 1664 |
|
|
2016
Q4 | – | Sell |
-28
| Closed | – | – | 1576 |
|
|
2016
Q3 | $0 | Sell |
28
-80,207
| -100% | -$510K | ﹤0.01% | 1575 |
|
|
2016
Q2 | $470K | Buy |
80,235
+40,118
| +100% | +$266K | ﹤0.01% | 1379 |
|
|
2016
Q1 | $255K | Buy |
+40,117
| New | +$215K | ﹤0.01% | 1324 |
|
Other funds holding SEM
8KM
HRCM
Macquarie Group's SEM Position: Q2 2025 in Review
Macquarie Group sold out of Select Medical (SEM) in Q2 2025, closing a stake of 33,800 shares — an estimated $564K sold.
Macquarie Group first reported a position in SEM in Q1 2016 and held it in 31 quarters. The position peaked at $81.2M in Q2 2021. 262 funds tracked by Wall St. Rank hold SEM as of Q2 2025.
- Macquarie Group reported no remaining Select Medical position as of Q2 2025 after selling out during the quarter.
- Macquarie Group sold 33,800 Select Medical shares in Q2 2025, an estimated $564K.
- Macquarie Group first reported a position in Select Medical in Q1 2016 and held it in 31 quarters.
- Macquarie Group's Select Medical position peaked at $81.2M in Q2 2021.
- 262 funds tracked by Wall St. Rank held Select Medical as of Q2 2025.
Based on Macquarie Group's 13F filing for Q2 2025, filed 14 Aug 2025.